NYSBA Annual Meeting January, 26-31:


Thursday, January 29, 2015
Food, Drug & Cosmetic Law Section Annual Meeting Program

Program will address important evolving FDA legal issues, including an FDA update on the Drug Quality and Security Act, Food Safety Modernization Act and Compounding Quality Act implementation programs; a medical device advertising panel featuring an invited FDA speaker; a discussion concerning FDA’s proposed framework to regulate laboratory developed tests; a Supreme Court and local FDA case update, including a further explanation of Myriad, pay-for-delay settlements in ANDA cases; the landmark private right of action Lanham Act case, POM Wonderful LLC v. Coca-Cola; the New York Attorney General’s pending antitrust suit against Actavis for planning to prematurely end sales of its Namenda drug for Alzheimer’s in order to force patients to switch to a newer version; an ethics program discussing issues surrounding representing companies manufacturing medical marijuana.

Meeting: 8:45 a.m. – 12:45 p.m. 

MCLE Credits Breakdown Coming Soon along with the Detailed Meeting Program